Showcasing Echomplish DMUT at the Invite-only TechTour event

Our Echomplish system represents a leap forward in precision ablation. By combining dual-mode ultrasound with real-time tissue monitoring, we’ve developed a miniature transcatheter device that delivers non-contact, continuous therapy with unprecedented accuracy. It’s designed to treat conditions like Atrial Fibrillation and hypertension more safely and effectively, using advanced signal and image processing to guide every pulse.

The feedback from investors, clinicians, and fellow entrepreneurs was incredibly encouraging. It’s clear that the future of interventional medicine lies in smarter, safer, and more adaptive technologies—and we’re proud to be helping lead that charge.

Thank you to the TechTour team for creating such a powerful platform for collaboration and innovation. We’re excited for what’s ahead.

The TechTour Growth Health 2024 conference, held from September 9–11 in Lausanne, Switzerland, brought together some of the most promising HealthTech startups and seasoned investors from across Europe. This 15th edition of the event showcased 41 growth-stage companies in Digital Health and MedTech, selected by a panel of 55 active investors.